Skip to content

Supplier News

Pepsi is more than OK in new Super Bowl ad campaign

Pepsi is more than OK in new Super Bowl ad campaign

Pepsi is no stranger to the Super Bowl and this year, the brand is using the world’s biggest stage to answer the question “Is Pepsi OK?,” showing the world – and the internet – once and for all that Pepsi is so much “more than OK!” The brand’s highly anticipated in-game advertisement, “More

Dr. Reddy’s gets FDA approval for Tosymra

Dr. Reddy’s gets FDA approval for Tosymra

Dr. Reddy’s Laboratories and its subsidiary, Promius Pharma. today announced the approval of Tosymra (previously known as DFN-02) by the U.S. Food and Drug Administration (FDA). Tosymra is indicated for the acute treatment of migraine with or without aura in adults.

Aurobindo receives FDA approval for dofetilide capsules

Aurobindo receives FDA approval for dofetilide capsules

Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for Dofetilide Capsules, 0.125 mg, 0.25 mg, and 0.5 mg. Aurobindo’s dofetilide capsules are an AB-rated generic equivalent to the reference listed drug, Pfizer’s Tikosyn.